The phase 3 DUO trial: duvelisib versus ofatumumab in relapsed and refractory CLL/SLL

Flinn, Ian W.; Hillmen, Peter; Montillo, Marco; Nagy, Zsolt [Nagy, Zsolt (Belgyógyászat, en...), author] I. Department of Internal Medicine (SU / FM / C); Illés, Árpád [Illés, Árpád (Orvostudományok), author] Institute of Internal Medicine Building B (UD / KK / BelgyKL); Etienne, Gabriel; Delgado, Julio; Kuss, Bryone J.; Tam, Constantine S.; Gasztonyi, Zoltán; Offner, Fritz; Lunin, Scott; Bosch, Francesco; Davids, Matthew S.; Lamanna, Nicole; Jaeger, Ulrich; Ghia, Paolo; Cymbalista, Florence; Portell, Craig A.; Skarbnik, Alan P.; Cashen, Amanda F.; Weaver, David T.; Kelly, Virginia M.; Turnbull, Barry; Stilgenbauer, Stephan

English Article (Journal Article) Scientific
Published: BLOOD 0006-4971 1528-0020 132 (23) pp. 2446-2455 2018
  • SJR Scopus - Biochemistry: D1
Subjects:
  • Clinical medicine
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-04 13:42